A közepes szénláncú zsírsavak és trigliceridek élettani hatásai, valamint lehetséges felhasználásuk a baromfi- és sertéstakarmányozásban : Irodalmi összefoglaló
Date
2024-11Author
Hetényi, Nikoletta
Bersényi, András
Hullár, István
DOI link
10.56385/magyallorv.2024.11.651-659Metadata
Show full item recordAbstract
The medium-chain fatty acids (MCFA), having 6-12 carbon atoms (caproic acid,
caprylic acid, capric acid, and lauric acid) are esterified to a glycerol backbone
forming the medium-chain-triglycerides (MCT). Coconut oil, palm/palm kernel oil,
and fat of the black soldier fly larvae (Hermetia illucens) are rich in these fatty acids.
MCFAs/MCTs display antibacterial activity against e.g. Staphylococcus aureus,
Mycobacterium tuberculosis, Escherichia coli, Salmonella Typhimurium, Clostridium
perfringens, Pseudomonas aeruginosa, however, the in vivo results are contra-
dictory. Accordingly, MCFAs have an impact on the gut microbiota. The antiviral
effects are less investigated, but in vitro MCFAs showed antiviral activity against
Porcine Epidemic Diarrhoea Virus, African Swine Fever and Vesicular Stomatitis
Virus. MCFAs are not effective against non-enveloped viruses. They also have
antifungal activity against Candida albicans, Aspergillus niger, and Fusarium spp.
MCFAs have shorter chain lengths, bile is not needed for their hydrolysis, thus they
are directly transported via the hepatic portal vein to the liver. MCFAs can enter the
mitochondria without L-carnitine, accordingly, they are quickly metabolized in the
body serving as an immediate energy source. MCFAs are anti-inflammatory and
can improve gut morphology (e.g.: the number of goblet cells and the intestinal
villi height increases) and the gut barrier. MCFAs improve insulin sensitivity and can
improve cognitive function and have anti-convulsant effects in epileptic patients.
Studies on poultries and pigs showed that MCT supplementation (0.25–15% in
the diet) might improve weight gain, feed conversion ratio, gut microbiota, and
gut morphology. However, the results of in vivo experiments are contradictory; no
adverse effects were shown. A higher (>8%) inclusion level of MCFAs decreases
the palatability of the feed and, accordingly, leads to lower feed intake. Further
animal studies are needed to determine the optimal inclusion rate of MCFA/MCT.